SMP
Stephan Bank & Martyna Sabat

Insights

Opportunities Are Our
Day-to-Day Business

Our clients are entrepreneurs – just like us. That's why we are passionate about developing new and sustainable solutions together with them.

SMP Deal Update: Current transactions News | Press

SMP is pleased to announce that over the last weeks, its Team had the honor of being involved in a further wide range of transactions in the startup sector.

Dr. Martin Schaper & Dr. Benjamin Ullrich June 22, 2021
SMP advises KKA on acquisition of Xantaro Group News | Press

SMP advised KKA on the structuring of its second fund and at the same time advised this fund on the acquisition of Xantaro Holding GmbH and its subsidiaries, Xantaro Deutschland GmbH and Xantaro UK Ltd.).

Dr. Jörn Wöbke June 11, 2021
SMP VC Deal Update: Current transactions News | Press

SMP is pleased to announce that over the last weeks, it had the honor of being involved in a further wide range of startup funding rounds in the venture capital sector.

Dr. Martin Schaper & Dr. Benjamin Ullrich June 04, 2021
SMP advises Leaps by Bayer on investment in Ada Health News | Press

SMP provided comprehensive legal advice to Leaps by Bayer on the Series B financing round of Berlin-based digital health company Ada Health.

Dr. Stephan Bank May 31, 2021
SMP advises Five Seasons Ventures on investment in vly News | Press

SMP advised the French investor Five Seasons Ventures on the Series A financing round of vly.

Dr. Frederik Gärtner & Dr. Benjamin Ullrich May 27, 2021
SMP advises Project A on Series C investment in Trade Republic News | Press

SMP advised early-stage investor and operating VC Project A on its Series C investment in FinTech Trade Republic.

Dr. Fabian Euhus May 21, 2021
SMP VC Deal Update News | Press

SMP is pleased to announce that over the last weeks, it had the honor of being involved in a further wide range of startup funding rounds in the venture capital sector.

Dr. Martin Schaper & Dr. Benjamin Ullrich May 12, 2021
SMP advises 1717 Life Science Ventures on sale of shares News | Press

SMP's Martin Schaper advised 1717 Life Science Ventures on the sale of its stake in drug developer PENTIXAPHARM to Eckert & Ziegler Strahlen- und Medizintechnik AG.

Dr. Martin Schaper May 11, 2021
SMP Briefing: Venture Capital Investments in Regulated FinTech and InsurTech Companies Briefing

According to the comdirect Fintech Study 2020, in 2019approximately € 1.755 billion in funding flowed into German FinTech companies in 149 financing rounds. Numerous of the most important German FinTech and InsurTech companies have their own regulatory licenses and are subject to direct supervision by the German Federal Financial Supervisory Authority (BaFin) and/or the German Federal Bank (Bundesbank). These authorities ensure that the applicable regulatory requirements are fulfilled and complied with.

Frederik Gärtner Dr. Frederik Gärtner May 07, 2021